Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo

Overview of attention for article published in BMC Cancer, September 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 37 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

H-1 PV EXPRESSING RNAi EFFECTORS

Application WO-2022219065-A1

World Intellectual Property Organisation (WIPO)

H-1 PV EXPRESSING RNAI EFFECTORS

Application EP-4074835-A1

European Patent Office

H-1 PV EXPRESSING RNAI EFFECTORS TARGETING CDK9

Application WO-2018096148-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.